DEVOTO, PAOLA
 Distribuzione geografica
Continente #
EU - Europa 151.963
NA - Nord America 9.544
AS - Asia 3.811
SA - Sud America 549
Continente sconosciuto - Info sul continente non disponibili 308
AF - Africa 76
OC - Oceania 3
Totale 166.254
Nazione #
IT - Italia 148.401
US - Stati Uniti d'America 9.409
SG - Singapore 1.512
CN - Cina 1.395
NL - Olanda 1.091
UA - Ucraina 637
SE - Svezia 615
BR - Brasile 426
DE - Germania 328
GB - Regno Unito 268
VN - Vietnam 265
FI - Finlandia 263
FR - Francia 197
HK - Hong Kong 113
IN - India 105
KR - Corea 104
CA - Canada 67
BD - Bangladesh 40
JP - Giappone 40
AR - Argentina 39
IQ - Iraq 35
MX - Messico 34
CO - Colombia 30
RU - Federazione Russa 29
PL - Polonia 28
TR - Turchia 28
ZA - Sudafrica 27
PK - Pakistan 23
ES - Italia 19
UZ - Uzbekistan 19
BE - Belgio 18
EC - Ecuador 18
MA - Marocco 17
CZ - Repubblica Ceca 14
ID - Indonesia 14
IR - Iran 14
PH - Filippine 13
VE - Venezuela 11
CR - Costa Rica 10
AT - Austria 9
AZ - Azerbaigian 9
JM - Giamaica 9
MY - Malesia 8
PS - Palestinian Territory 8
AE - Emirati Arabi Uniti 7
IE - Irlanda 7
KE - Kenya 7
CL - Cile 6
JO - Giordania 6
MU - Mauritius 6
PE - Perù 6
SA - Arabia Saudita 6
DZ - Algeria 5
LB - Libano 5
PT - Portogallo 5
PY - Paraguay 5
BG - Bulgaria 4
BY - Bielorussia 4
CH - Svizzera 4
EU - Europa 4
HU - Ungheria 4
IL - Israele 4
KG - Kirghizistan 4
KZ - Kazakistan 4
PA - Panama 4
UY - Uruguay 4
AM - Armenia 3
BN - Brunei Darussalam 3
EG - Egitto 3
LK - Sri Lanka 3
LT - Lituania 3
NP - Nepal 3
OM - Oman 3
TH - Thailandia 3
TN - Tunisia 3
AL - Albania 2
AU - Australia 2
BB - Barbados 2
BO - Bolivia 2
HN - Honduras 2
KW - Kuwait 2
MD - Moldavia 2
QA - Qatar 2
RO - Romania 2
SN - Senegal 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
AO - Angola 1
BS - Bahamas 1
BW - Botswana 1
CG - Congo 1
CI - Costa d'Avorio 1
CW - ???statistics.table.value.countryCode.CW??? 1
CY - Cipro 1
DO - Repubblica Dominicana 1
EE - Estonia 1
FJ - Figi 1
GE - Georgia 1
GH - Ghana 1
GR - Grecia 1
Totale 165.934
Città #
Cagliari 143.895
Uta 4.057
Amsterdam 1.069
Fairfield 898
Ashburn 879
Singapore 726
Woodbridge 713
Chandler 618
Houston 552
San Jose 524
Ann Arbor 418
Seattle 374
Dallas 358
Boardman 341
Jacksonville 337
Nyköping 336
Wilmington 323
Dearborn 291
Cambridge 280
Beijing 236
Los Angeles 169
Helsinki 162
Council Bluffs 150
Hefei 131
The Dalles 126
Santa Clara 124
Nanjing 114
Lauterbourg 104
Hong Kong 103
Shanghai 95
Seoul 94
Boston 92
Ho Chi Minh City 88
San Diego 82
New York 67
Hanoi 63
Buffalo 61
Shenyang 50
Munich 48
Milan 45
Guangzhou 39
Nanchang 37
São Paulo 37
Orem 33
Hebei 32
London 32
Frankfurt am Main 31
Redwood City 30
Tianjin 29
Chicago 28
Washington 28
Redondo Beach 25
San Francisco 25
Tokyo 25
Brooklyn 23
Changsha 23
Columbus 22
Dong Ket 22
Verona 22
Montreal 21
Johannesburg 20
Santa Maria Coghínas 20
Kunming 19
Toronto 19
Warsaw 19
Atlanta 18
Brussels 18
Mountain View 18
Norwalk 18
Phoenix 18
Pune 18
San Mateo 18
Zhengzhou 18
Orange 17
Tashkent 17
Chennai 16
Detroit 16
Jiaxing 16
Jinan 16
Mumbai 16
Rio de Janeiro 16
Rome 16
Denver 15
Manchester 14
Ningbo 13
Leawood 12
Augusta 11
Bogotá 11
Da Nang 11
Falls Church 11
Auburn Hills 10
Baghdad 10
Brasília 10
Brno 10
Shenzhen 10
Stockholm 10
Casablanca 9
Monmouth Junction 9
Ankara 8
Baku 8
Totale 160.336
Nome #
5alpha-reductase inhibitors dampen L-DOPA-induced dyskinesia via normalization of dopamine D1-receptor signaling pathway and D1-D3 receptor interaction 5.833
Maternal immune activation disrupts dopamine system in the offspring 4.164
The 5-alpha reductase inhibitor finasteride reduces dyskinesia in a rat model of Parkinson's disease 4.089
The neurosteroidogenic enzyme 5α-reductase mediates psychotic-like complications of sleep deprivation 3.924
Selective inhibition of dopamine-beta-hydroxylase enhances dopamine release from noradrenergic terminals in the medial prefrontal cortex 3.516
The neurosteroidogenic enzyme 5α-reductase modulates the role of D1 dopamine receptors in rat sensorimotor gating 3.285
Elevated dopamine in the medial prefrontal cortex suppresses cocaine seeking via D1 receptor overstimulation 3.040
Gene-environment interactions in antisocial behavior are mediated by early-life 5-HT2A receptor activation 3.036
null 2.940
Selective activation of D1 dopamine receptors impairs sensorimotor gating in Long-Evans rats 2.893
Noradrenergic terminals are the primary source of α2-adrenoceptor mediated dopamine release in the medial prefrontal cortex 2.878
Inhibition of 17α-hydroxylase/C17,20 lyase reduces gating deficits consequent to dopaminergic activation 2.786
Targeting neurosteroid synthesis as a therapy for schizophrenia-related alterations induced by early psychosocial stress 2.739
The PPARα agonist fenofibrate attenuates disruption of dopamine function in a maternal immune activation rat model of schizophrenia 2.734
Inhibition of steroid 5-alpha reductase reduces marble-burying responses in mice 2.714
NMDARs mediate the role of monoamine oxidase A in pathological aggression 2.629
Positive allosteric modulation of GABAB receptors ameliorates sensorimotor gating in rodent models 2.611
Inhibition of 5 alpha-reductase in the nucleus accumbens counters sensorimotor gating deficits induced by dopaminergic activation 2.611
Allopregnanolone mediates manic-like outcomes of REM sleep deprivation 2.532
Effects of maternal immune activation on dopamine activity in male and female offspring 2.464
Levodopa prevents the reinstatement of cocaine self-administration in rats via potentiation of dopamine release in the medial prefrontal cortex 2.434
Startle Reflex as a possible biomarker associated with REM sleep behavior disorders in the prodromal stage of Parkinson's disease 2.350
Blockade of 5-alpha reductase reduces compulsive behaviors in mice 2.319
Inhibition of 5α-reductase attenuates behavioral effects of D1-, but not D2-like receptor agonists in C57BL/6 mice 2.288
Allopregnanolone mediates manic-like outcomes of REM sleep deprivation 2.281
Noradrenaline neuron degeneration contributes to motor impairments and development of L-DOPA-induced dyskinesia in a rat model of Parkinson's disease 2.271
Modulation of the Startle Response in REM Sleep Behavior Disorder 2.269
Juvenile cannabinoid treatment induces frontostriatal gliogenesis in Lewis rats 2.155
NMDA receptors mediate the role of monoamine oxidase A in pathological aggression 2.085
Disulfiram stimulates dopamine release from noradrenergic terminals and potentiates cocaine-induced dopamine release in the prefrontal cortex 2.057
The steroid 5-alpha reductases mediate the abnormalities in information processing and attention mechanisms induced by REM sleep deprivation 2.028
The levels of the NMDA receptor co-agonist D-serine are reduced in the substantia nigra of MPTP-lesioned macaques and in the cerebrospinal fluid of Parkinson’s disease patients 2.025
6-Hydroxydopamine lesion in the ventral tegmental area fails to reduce extracellular dopamine in the cerebral cortex 1.940
null 1.934
Antipsychotic-like properties of antiandrogenic drugs: focus on dopaminergic system 1.877
The implication of neuroactive steroids in tourette's syndrome pathogenesis: A role for 5α-reductase? 1.870
Reserpine treatment ablates the deficits of sensorimotor gating induced by dopamine D3 receptor activation in Sprague-Dawley, but not Long-Evans rats 1.849
Inhibition of 5-alpha reductase elicits antipsychotic-like effects via post-synaptic mechyanisms in nucleus accumbens and prefrontal cortex 1.832
Co-release of noradrenaline and dopamine in the cerebral cortex elicited by single train and repeated train stimulation of the locus coeruleus 1.820
Prenatal THC exposure produces a hyperdopaminergic phenotype rescued by pregnenolone 1.781
null 1.722
5-alpha reductase expression is reduced in brain of isolation-reared rats: relevance to dopaminergic impairments 1.715
Inhibition of 5α-reductase counters the behavioral effects of D1, but not D2 dopamine receptor activation 1.638
Noradrenergic Source of Dopamine Assessed by Microdialysis in the Medial Prefrontal Cortex 1.635
Isolation rearing-induced reduction of brain 5 alpha-reductase expression: Relevance to dopaminergic impairments 1.627
Pramipexole enhances disadvantageous decision-making: Lack of relation to changes in phasic dopamine release 1.603
Alpha2-adrenoceptor mediated co-release of dopamine and noradrenaline from noradrenergic neurons in the cerebral cortex 1.601
Fasting biases µ-opioid receptors toward β–arrestin2-dependent signaling in the accumbens shell 1.536
Exploring the neural mechanisms of finasteride: a proteomic analysis in the nucleus accumbens 1.494
Midbrain 6-OHDA lesion fails to reduce extracellular dopamine in cerebral cortex. 1.483
Inhibition of 5-alpha reductase elicits antipsychotic-like effects via post-synaptic mechanisms in nucleus accumbens and prefrontal cortex 1.467
Stimulation of the locus coeruleus elicits noradrenaline and dopamine release in the medial prefrontal and parietal cortex 1.457
Mirtazapine-induced corelease of dopamine and noradrenaline from noradrenergic neurons in the medial prefrontal and occipital cortex 1.389
The genetic deletion of monoamine oxidase (MAO) gene promotes autistic-like phenotypes in mice 1.367
Role of Dopamine D2/D3 Receptors in Development, Plasticity, and Neuroprotection in Human iPSC-Derived Midbrain Dopaminergic Neurons 1.367
Dopamine-beta-hydroxylase inhibition potentiates cocaine effect on dopamine release in the medial prefrontal cortex 1.347
Origin of extracellular dopamine from dopamine and noradrenaline neurons in the medial prefrontal and occipital cortex 1.333
Effects of post-weaning social isolation on 5-alpha reductase: Relevance to dopaminergic pathway 1.319
The control of responsiveness in ADHD by catecholamines: evidence for dopaminergic, noradrenergic and interactive roles 1.317
Altered expression level of nucleus accumbens proteins in isolation-reared rats 1.302
EFFECT OF NORADRENERGIC DENERVATION ON CEREBRAL CORTEX CATECHOLAMINES IN THE RAT 1.285
Early postnatal inhibition of serotonin synthesis results in long-term reductions of perseverative behaviors, but not aggression, in MAO A-deficient mice 1.165
Steroid 5 alpha-reductase as a novel therapeutic target for schizophrenia and other neuropsychiatric disorders 1.100
null 1.078
Thymic oxytocin like immunoreactivity is increased in morphine tolerant dependent rats 1.009
Lead intoxication during intrauterine life and lactation but not during adulthood reduces nucleus accumbens dopamine release as studied by brain microdialysis 928
Dissociation of haloperidol, clozapine, and olanzapine effects on electrical activity of mesocortical dopamine neurons and dopamine release in the prefrontal cortex 922
5-Hydroxy-tryptophan for the treatment of l-DOPA-induced dyskinesia in the rat Parkinson's disease model 905
5-alpha reductase inhibitors as a novel therapy for Tourette Syndrome: Clinical Evidence 841
Detection of 3H-cimetidine specific binding in rat anterior pituitary 777
5-Alpha reductase inhibitors modulate dopaminergic signaling: relevance to psychosis 776
Biochemical and electrophysiological effects of 7-OH-DPAT on the mesolimbic dopaminergic system 716
Disulfiram and diethylditiocarbamate intoxication affects the storage and release of striatal dopamine 658
Impaired dopamine D3 and nicotinic acetylcholine receptor membrane localization in iPSCs-derived dopaminergic neurons from two Parkinson’s disease patients carrying the LRRK2 G2019S mutation 646
Biochemical characterization of rat forebrain septum dopaminergic innervation. 634
The potent α2-adrenoceptor antagonist RS 79948 also inhibits dopamine D2 -receptors: Comparison with atipamezole and raclopride 626
Central dopaminergic transmission is selectively increased in the limbic system of rats chronically exposed to antidepressants 623
Chronic SCH 23390 produces tolerance to morphine extrapiramidal effects 601
Prenatal THC Does Not Affect Female Mesolimbic Dopaminergic System in Preadolescent Rats 540
Decreased adenosine A2 receptor function in morphine dependent rats 533
Chronic imipramine reduces [3H]SCH 23390 binding and DA sensitive adenylate cyclase in the limbic system 527
Selective adenylate cyclase increase in the limbic area of long term imipramine treated rats 516
Evidence that cortical dopamine is a co-transmitter in noradrenergic neurons 515
Resistance to extrapyramidal effects of opiates in rats chronically treated with SCH 23390 511
Effect of calcium antagonists on [3H] dopamine uptake 510
Delta(9)-tetrahydrocannabinol decreases extracellular GABA and increases extracellular glutamate and dopamine levels in the rat prefrontal cortex: an in vivo microdialysis study 485
null 470
On the origin of cortical dopamine: Is it a co-transmitter in noradrenergic neurons? 469
The dopamine beta-hydroxylase inhibitor nepicastat increases dopamine release and potentiates psychostimulant-induced dopamine release in the prefrontal cortex 454
Opioid activity of lefetamine 449
Labetalol blockade of central alpha- and beta-noradrenergic receptors in rat brain homogenates 438
Co-release of dopamine and noradrenaline from noradrenergic neurons in the cerebral cortex: implication for the neurobiology of psychiatric disorders 412
Gating deficits in isolation-reared rats are correlated with alterations in protein expression in nucleus accumbens 412
[3H] spiroperidol binding to a putative dopaminergic receptor in rat pituitary gland 412
Differential effect of Mu, Delta, and kappa opioid agonists on adenylate cyclase activity 407
Possible antidepressant activity of methadone 406
Adrenergic sensitive adenylate cyclase in rat posterior pituitary 403
Opiate k receptors agonists do not inhibit adenylate cyclase activity 397
Behavioural sensitization of mesolimbic dopamine D2 receptors in chronic fluoxetine-treated rats 397
In utero exposure to methadone produces a stable decrease of the cortex 5-HT transport system in rats 390
Totale 159.945
Categoria #
all - tutte 215.466
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 215.466


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20227.524 0 581 730 497 582 688 581 540 606 765 906 1.048
2022/202311.543 1.070 1.439 1.147 953 994 1.182 651 811 901 800 1.045 550
2023/202412.011 622 500 464 656 1.148 1.638 1.812 737 753 892 1.228 1.561
2024/202520.023 3.958 4.608 3.873 1.955 1.021 1.084 1.234 175 326 1.273 234 282
2025/20266.614 501 286 748 464 599 469 1.058 339 463 668 384 635
2026/2027571 295 276 0 0 0 0 0 0 0 0 0 0
Totale 166.254